JP2024529763A5 - - Google Patents
Info
- Publication number
- JP2024529763A5 JP2024529763A5 JP2024510406A JP2024510406A JP2024529763A5 JP 2024529763 A5 JP2024529763 A5 JP 2024529763A5 JP 2024510406 A JP2024510406 A JP 2024510406A JP 2024510406 A JP2024510406 A JP 2024510406A JP 2024529763 A5 JP2024529763 A5 JP 2024529763A5
- Authority
- JP
- Japan
- Prior art keywords
- pxrd
- pattern
- crystalline material
- methyl
- room temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163235635P | 2021-08-20 | 2021-08-20 | |
| US63/235,635 | 2021-08-20 | ||
| PCT/US2022/040884 WO2023023322A1 (en) | 2021-08-20 | 2022-08-19 | Crystal forms of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-d3)pyridazine-3-carboxamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529763A JP2024529763A (ja) | 2024-08-08 |
| JP2024529763A5 true JP2024529763A5 (https=) | 2025-08-26 |
Family
ID=83283223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024510406A Pending JP2024529763A (ja) | 2021-08-20 | 2022-08-19 | ６－（シクロプロパンカルボキサミド）－４－（（２－メトキシ－３－（１－メチル－１ｈ－１，２，４－トリアゾール－３－イル）フェニル）アミノ）－ｎ－（メチル－ｄ３）ピリダジン－３－カルボキサミドの結晶体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240368130A1 (https=) |
| EP (1) | EP4387968B1 (https=) |
| JP (1) | JP2024529763A (https=) |
| KR (1) | KR20240050380A (https=) |
| CN (1) | CN118119614A (https=) |
| ES (1) | ES3062193T3 (https=) |
| WO (1) | WO2023023322A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024241347A1 (en) * | 2023-05-25 | 2024-11-28 | Msn Laboratories Private Limited, R&D Center | Novel polymorphs of 6-(cyclopropanecarbonylamido)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-n-(trideuteriomethyl)pyridazine-3-carboxamide |
| ES3059443A1 (es) * | 2024-09-17 | 2026-03-20 | Moehs Iberica Sl | Forma solida de 6-(ciclopropanocarboxamido)-4-((2-metoxi-3-(1-metil-1h-1,2,4-triazol-3-il)fenil)amino)piridazine-3-carboxilato de metilo o una sal del mismo, procedimiento para su preparacion y su uso en la sintesis de deucravacitinib |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3495358T (lt) * | 2012-11-08 | 2022-05-25 | Bristol-Myers Squibb Company | Amidais pakeisti heterocikliniai junginiai, naudingi kaip il-12, il-23 ir (arba) ifn alfa atsako moduliatoriai |
| JP7113023B2 (ja) | 2017-03-30 | 2022-08-04 | ブリストル－マイヤーズ スクイブ カンパニー | ６－（シクロプロパンアミド）－４－（（２－メトキシ－３－（１－メチル－１ｈ－１，２，４－トリアゾール－３－イル）フェニル）アミノ）－ｎ－（メチル－ｄ３）ピリダジン－３－カルボキシアミドの製造方法 |
| KR102848769B1 (ko) | 2018-05-31 | 2025-08-20 | 브리스톨-마이어스 스큅 컴퍼니 | 6-(시클로프로판카르복스아미도)-4-((2-메톡시-3-(1-메틸-1h-1,2,4-트리아졸-3-일)페닐)아미노)-n-(메틸-d3) 피리다진-3-카르복스아미드의 결정질 형태 |
| US12570637B2 (en) | 2019-06-12 | 2026-03-10 | Bristol-Myers Squibb Company | Crystalline salt forms 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyld3) pyridazine-3-carboxamide |
| KR20230137962A (ko) * | 2021-01-29 | 2023-10-05 | 브리스톨-마이어스 스큅 컴퍼니 | 6-(시클로프로판카르복스아미도)-4-((2-메톡시-3-(1-메틸-1h-1,2,4-트리아졸-3-일)페닐)아미노)-n-(메틸-d3)피리다진-3-카르복스아미드의 결정 형태 |
| CN117377667A (zh) * | 2021-03-29 | 2024-01-09 | 百时美施贵宝公司 | 6-(环丙烷甲酰胺基)-4-((2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯基)氨基)-N-(甲基-d3)哒嗪-3-甲酰胺的晶型 |
-
2022
- 2022-08-19 EP EP22769445.2A patent/EP4387968B1/en active Active
- 2022-08-19 CN CN202280068807.1A patent/CN118119614A/zh active Pending
- 2022-08-19 US US18/684,747 patent/US20240368130A1/en active Pending
- 2022-08-19 KR KR1020247008835A patent/KR20240050380A/ko active Pending
- 2022-08-19 ES ES22769445T patent/ES3062193T3/es active Active
- 2022-08-19 JP JP2024510406A patent/JP2024529763A/ja active Pending
- 2022-08-19 WO PCT/US2022/040884 patent/WO2023023322A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024529763A5 (https=) | ||
| JP2024505063A5 (https=) | ||
| TWI406661B (zh) | ４-甲基-ｎ-〔３-（４-甲基-咪唑-１-基）-５-三氟甲基-苯基〕-３-（４-吡啶-３-基-嘧啶-２基胺基）-苯甲醯胺之結晶型 | |
| JP2020512380A5 (https=) | ||
| JP2024514090A5 (https=) | ||
| FI3964510T3 (fi) | Wee1-inhibiittoriyhdisteen kidemuoto ja sen käyttö | |
| JP2023082086A5 (https=) | ||
| JP2023036708A5 (https=) | ||
| JP3665053B2 (ja) | 純結晶形態の５−クロロ−３−（４−メタンスルホニルフェニル）−６’−メチル−［２，３’］ビピリジニルおよび合成方法 | |
| JP2012527442A5 (https=) | ||
| JP2009521414A5 (https=) | ||
| JP2022533340A5 (https=) | ||
| CN101139325B (zh) | 2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸晶型及其制备方法 | |
| AU2001264804A1 (en) | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis | |
| KR20170057441A (ko) | Jak 억제제의 바이설페이트의 결정형 및 이의 제조방법 | |
| JP2022540922A5 (https=) | ||
| JP2018522945A5 (https=) | ||
| CN111793074B (zh) | K-5a2化合物的晶型及其制备方法和应用 | |
| KR102657147B1 (ko) | 빌라스틴의 결정형 및 그의 제조 방법 | |
| JP2025102940A5 (https=) | ||
| US20030153600A1 (en) | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis | |
| JP6818031B2 (ja) | モルホリン誘導体の塩、結晶形、その製造方法、これらを含む医薬組成物およびその用途 | |
| CN120483962A (zh) | 一种烟嘧磺隆Ia晶型的制备方法及其应用 | |
| TWI687412B (zh) | 製備吡蟲啉（ｉｍｉｄａｃｌｏｐｒｉｄ）多晶型的方法 | |
| JP2010502682A5 (https=) |